Date | Title | |
December 19, 2016 | BeyondSpring Presents Encouraging Clinical Data for Lead Asset on Chemotherapy-Induced Neutropenia at 2016 ASH Annual Meeting |  |
November 3, 2016 | BeyondSpring Clinical Data on Neutropenia Mitigation with Plinabulin to be Presented at 2016 ASH Annual Meeting |  |
September 27, 2016 | BeyondSpring Announces First Patient Enrolled in Phase 1b/2 Investigator-Initiated Trial of Plinabulin plus Nivolumab for Non-Small Cell Lung Cancer |  |
September 12, 2016 | BeyondSpring Chief Medical Officer to Present at BioPharm America 2016 |  |
August 15, 2016 | BeyondSpring Announces First Patient Enrolled in China in a Global Phase 3 Trial of Plinabulin for Non-Small Cell Lung Cancer |  |
July 14, 2016 | Investigator-Sponsored Plinabulin Combination Study for Metastatic Non-Small Cell Lung Cancer Granted FDA Clearance to Enroll Patients |  |
June 28, 2016 | BeyondSpring’s Global Phase III Non-Small Cell Lung Cancer Clinical Trial for Plinabulin Launches in China |  |
May 26, 2016 | American Society of Clinical Oncology Selects BeyondSpring Abstract on Neutropenia Mitigation with Plinabulin Use for Publication |  |
May 12, 2016 | BeyondSpring Chief Medical Officer Served as Panelist at NewYorkBIO |  |
May 9, 2016 | BeyondSpring Chief Medical Officer to Serve as Panelist at Chief Medical Officer Summit |  |
April 18, 2016 | BeyondSpring CMO Presented at BIO Spring 2016 |  |
February 24, 2016 | BeyondSpring Pharmaceuticals to Present Today at 4th Annual Cancer Biopartnering & Investment Forum in NYC |  |
February 8, 2016 | BeyondSpring Pharmaceuticals’ Data Indicating Plinabulin Enhances Immune Response Provides Basis for Planned Phase I/II Combination Trial in NSCLC |  |
February 3, 2016 | BeyondSpring Pharmaceuticals to Present at 18th Annual BIO CEO & Investor Conference |  |
January 7, 2016 | BeyondSpring Pharmaceuticals to Present at 8th Annual Biotech Showcase |  |
January 6, 2016 | BeyondSpring Pharmaceuticals and Fred Hutchinson Cancer Research Center Enter Collaboration Agreement |  |
January 5, 2016 | BeyondSpring Pharmaceuticals to Present Plinabulin-Immune System Interactions at AACR’s 2016 Tumor Microenvironment Special Conference |  |